
Dei BioPharma
@deibiopharma
We aspire to become a globally acclaimed pharmaceutical company that produces a diverse portfolio of vaccines and low cost drugs
ID: 1842134608361463808
04-10-2024 09:28:24
18 Tweet
51 Followers
6 Following



VIDEO: Ministry of Finance, Matia Kasaija, while presenting the National Budget 2025/2026, said the government continues to prioritise the science, technology, and innovation sector with emphasis on Dei BioPharma. #NBSLiveAt9 #NBSUpdates



Dr. Matthias Magoola (@DeiBiopharma) receives prestigious Faces of Science Award! 🏆 This groundbreaking work in biotech & pharma innovation is putting 🇺🇬 on the map.👏 The Kampala Report @STI_UG Government of Uganda thekampalareport.com/latest/2025062…

Big win for science in Africa Dr. Matthias Magoola of Dei BioPharma has been honoured with the Faces of Science Award for transforming Uganda into a biotech powerhouse 🎖️Over 100 patents 🧫 RNA-based therapies 💊 Local vaccine production #FacesOfScience #DeiBioPharma #STI2025






In pharma, small errors cost big. That’s why we train for more than just science. On 26 June, Dei BioPharma staff joined @mforteconsult for a powerful session on teamwork, communication, and personal presence. Because how we work matters as much as what we make. #DeiBioPharma


From 💲28,000/year to less than 💲50. Uganda’s Dei BioPharma to locally produce Lenacapavir (Yeztugo), a breakthrough HIV drug making it Africa’s first complete HIV treatment manufactured for LDCs. Read here : nilepost.co.ug/news/267404/de…






A proud moment at DEI BioPharma as we hosted a high-level delegation from Uganda Registration Services Bureau 🇺🇬 Though Dr. Magoola wasn’t present, our CEO Hitesh Upreti gave a full tour, showcasing our IP-led innovation. #MadeInAfrica #Biotech #IP


Honored to share Dr. Matthias Magoola’s inspiring journey in the inaugural issue of The Publicist Don’t miss it: lnkd.in/e3PeyeXF #DEIBioPharma